Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01RX002682-01 |
| Title: | Lipoic acid for the treatment of progressive multiple sclerosis |
| Principal Investigator: | Rebecca Spain |
| Location: | Portland, OR |
| Congressional District Code: | 3 |
| Research Service: | Rehabilitation R&D |
| Project Period: | May 2018 - April 2022 |
| FY 2021 Funding Amount: | $268,767 |
| Total Award Amount (all years): |
$1,050,564 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: At any time, nearly half of the 500,000 people in the United States living with multiple sclerosis (MS), a common and disabling neuro-inflammatory disease of the central nervous system, have a progressive course. Despite the explosion of new MS therapies, there remains a frustrating lack of disease-modifying therapies that can alter the functional decline of progressive MS (PMS) that resulting in reduced community participation, low quality of life, and high burdens on health care systems and ca... |